Acousia Therapeutics to present its clinical Phase 2 PROHEAR study on hearing loss treatment candidate ACOU085 at upcoming conferences

By on    Electronics & Semiconductors, Picture Gallery  

Acousia Therapeutics to present its clinical Phase 2 PROHEAR study on hearing loss treatment candidate ACOU085 at upcoming conferences

Acousia Therapeutics GmbH, a Tübingen-based clinical stage biotech company focused on the enhancement and preservation of natural hearing, will be presenting the ACOU085 Phase 2 PROHEAR clinical study at the HansonWade 4th Inner Ear Disorders Therapeutics Summit in Boston (MA) from August 20–22, and at the 36th World Congress of Audiology from September 19–22, 2024.

The PROHEAR study is a placebo-controlled Phase 2a study with split-body design investigating the otoprotective

Latest Trend Study: Innovative Technologies are changing SAP© Application Management / Companies expect cost savings of up to 30 percent through AI

By on    Internet, Picture Gallery  

Latest Trend Study: Innovative Technologies are changing SAP© Application Management / Companies expect cost savings of up to 30 percent through AI

– Increasing complexity of the IT landscape makes seamless integration and communication between SAP and non-SAP applications a central concern for respondents.
– Cloud is the trend: Over 70 percent of the surveyed companies opt for the latest version of SAP S/4HANA, preferably in the cloud.
– High demands on SAP partners: Competencies in the security of SAP systems and smooth operation are among the must-have criteria at 77 percent.

To better understand the current status quo and future